((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
Overview
* US cord blood bank's fiscal Q3 revenue was flat yr/yr
* Net income and EPS rose yr/yr in fiscal Q3
Outlook
* Company did not provide specific financial guidance for future periods
Result Drivers
FLAT REVENUE - Co did not provide specific reasons for its financial results
* HIGHER NET INCOME - Co did not attribute net income increase to specific factors
Company press release: ID:nBw8rBtBDa
Key Details
Metric Beat/Mis Actual Consensu
s s
Estimate
Q3 $7.82
Revenue mln
Q3 EPS $0.16
Q3 Net $1.27
Income mln
Analyst Coverage
* The one available analyst rating on the shares is "hold"
* The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Reuters Recommended Reads
* Oct 9 - Bagel franchisor BAB's Q3 net income rises 36% on lower overhead costs
* Oct 7 - Consulting firm Resources Connection's Q1 net loss widens on lower project volume
* Oct 7 - Cosmos Health Q3 revenue rises to record high on contract manufacturing
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)